Skip to content
OpenPharmaceutical productscs

Dodávky léčivých přípravků - Biologika XI[E15]

Praha, CzechiaFakultní nemocnice Královské Vinohrady[E2]

In plain English

What they want
Předmětem veřejné zakázky jsou opakované dodávky léčivých přípravků pro pacienty zadavatele. Veřejná zakázka je rozdělena na 7 částí ve smyslu ustanovení § 35 zákona. Předmětem plnění jsou přípravky ofatumumab, ocrelizumab, brentuximab vedotin, rituximab, obinutuzumab, pembrolizumab, denosumab. Na každou část podává dodavatel samostatnou nabídku.
Who can bid
No restrictions are stated in the notice data. The tender documents may set more.
Deadline
Buyer's deadline: 26 Nov 2026, 10:00 UTC+1. UTC: 26 Nov 2026, 09:00 UTC.
Published 27 Oct 2026.
Value
CZK 735,725,000
Buyer
Fakultní nemocnice Královské VinohradySee what else this buyer buys and when.
Tender documents

We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Tender documents, read for you

We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Get the key points of the tender pack, with page references

A summary of what the documents require, a bid or no-bid checklist against your company profile, and answers to your questions with the page they come from.

Your tender documents

Download the tender pack from the buyer's portal (the invitation to tender, specification, selection questionnaire, scoring and draft contract) and add it here. We read every page and check it against your company for the bid assessment.

Sign in to upload documents.

Deadline[E6]
26 Nov 2026, 10:00 UTC+1
Value[E16]
CZK 735,725,000
Published[E14]
27 Oct 2026
Procedure[E13]
open
Last checked
27 minutes ago

About the requirement

From the notice

Předmětem veřejné zakázky jsou opakované dodávky léčivých přípravků pro pacienty zadavatele. Veřejná zakázka je rozdělena na 7 částí ve smyslu ustanovení § 35 zákona. Předmětem plnění jsou přípravky ofatumumab, ocrelizumab, brentuximab vedotin, rituximab, obinutuzumab, pembrolizumab, denosumab. Na každou část podává dodavatel samostatnou nabídku.[E7]

Eligibility and requirements

  • ConditionPlace of performance: NUTS CZ010.[E8]
  • ConditionThe buyer marks the procurement as suitable for small and medium-sized businesses.[E9]
  • ConditionThe procurement is covered by the WTO Government Procurement Agreement.[E10]
  • DetailAward criteria types: price.[E1]
  • DetailThe contract duration is 2 YEAR.[E4]
  • The notice data states no restriction on who may bid. Exclusion grounds and selection criteria in the tender documents still apply.

Risks and unknowns

  • RiskThe official language is CES. Documents and bids may need to be in that language.[E12]
  • UnknownWe read the published notice, not the full tender documents.

Updates

  1. First seen · 28 Oct 2026, 09:20 UTC

    The source published a call for competition with a future deadline.

    Source document 747692-2026

Evidence

16 facts

Every fact on this page comes from the published notice. Each entry shows the document and the field it was read from.

  1. E1

    Award criteria types: price.

    Document 747692-2026, field /award-criterion-type-lot, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  2. E2

    The buyer is Fakultní nemocnice Královské Vinohrady.

    Document 747692-2026, field /buyer-name/ces, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  3. E3

    The notice is classified under CPV 33600000.

    Document 747692-2026, field /classification-cpv/0, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  4. E4

    The contract duration is 2 YEAR.

    Document 747692-2026, field /duration-period-value-lot/0, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  5. E5

    The buyer is in CZE.

    Document 747692-2026, field /buyer-country/0, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  6. E6

    Tenders must be received by 26 Nov 2026, 10:00 UTC+01:00.

    “2026-11-26+01:00 10:00:00+01:00”

    Document 747692-2026, field /deadline-receipt-tender-date-lot/0, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  7. E7

    The buyer describes the requirement (in ces).

    “Předmětem veřejné zakázky jsou opakované dodávky léčivých přípravků pro pacienty zadavatele. Veřejná zakázka je rozdělena na 7 částí ve smyslu ustanovení § 35 zákona. Předmětem plnění jsou přípravky ofatumumab, ocrelizumab, brentuximab vedotin, rituximab, obinutuzumab, pembroliz…”

    Document 747692-2026, field /description-proc/ces, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  8. E8

    Place of performance: NUTS CZ010.

    Document 747692-2026, field /place-of-performance, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  9. E9

    The buyer marks the procurement as suitable for small and medium-sized businesses.

    “true”

    Document 747692-2026, field /sme-lot, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  10. E10

    The procurement is covered by the WTO Government Procurement Agreement.

    “true”

    Document 747692-2026, field /gpa-lot, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  11. E11

    This is a call for competition. Suppliers can respond. TED notice type: cn-standard.

    Document 747692-2026, field /notice-type, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  12. E12

    The procedure title in ces is "Dodávky léčivých přípravků - Biologika XI".

    Document 747692-2026, field /title-proc/ces, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  13. E13

    The procedure type is open.

    Document 747692-2026, field /procedure-type, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  14. E14

    TED published the notice on 28 Oct 2026.

    “2026-10-28+01:00”

    Document 747692-2026, field /publication-date, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  15. E15

    The notice is titled "Czechia – Pharmaceutical products – Dodávky léčivých přípravků - Biologika XI".

    Document 747692-2026, field /notice-title/eng, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

  16. E16

    The estimated value is CZK 735,725,000.

    “735725000 CZK”

    Document 747692-2026, field /estimated-value-proc, read 28 Oct 2026, 09:20 UTC · source (opens in a new tab)

Source: Tenders Electronic Daily (TED), © European Union. Reuse authorised under Commission Decision 2011/833/EU. Data licence: EU reuse of TED data (Commission Decision 2011/833/EU) (opens in a new tab). Personal contact details in notices are not stored or shown.